instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chills'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Influenza like illness'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injection site pain'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphoedema'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant melanoma'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lymph nodes'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastasis'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial infarction'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ulcer'. | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | TALIMOGENE LAHERPAREPVEC | DrugsGivenReaction | CC BY-NC | 34290528 | 16,836,541 | 2021 |
What was the outcome of reaction 'Myocardial infarction'? | Real-World Experience of Talimogene Laherparepvec (T-VEC) in Old and Oldest-Old Patients with Melanoma: A Retrospective Single Center Study.
Rising melanoma incidences lead to an increasing need for individual therapy strategies in old patients. Talimogene laherparepvec (T-VEC) is a modified herpes simplex virus, appro... | Fatal | ReactionOutcome | CC BY-NC | 34290528 | 16,836,541 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Hypertrophic Gastric folds with Hypomagnesemia, linking the dots.
A Caucasian man in early 80s was seen in Gastroenterology Clinic, following, referral from the Endocrinology Clinic for concerns for CT Abdomen requested for tiredness and weight loss of three kilograms. The patient also had microcytic picture with low M... | OMEPRAZOLE | DrugsGivenReaction | CC BY | 34290814 | 20,126,514 | 2021 |
What was the dosage of drug 'MAGNESIUM'? | Hypertrophic Gastric folds with Hypomagnesemia, linking the dots.
A Caucasian man in early 80s was seen in Gastroenterology Clinic, following, referral from the Endocrinology Clinic for concerns for CT Abdomen requested for tiredness and weight loss of three kilograms. The patient also had microcytic picture with low M... | 24 MMOL | DrugDosageText | CC BY | 34290814 | 20,145,803 | 2021 |
What was the outcome of reaction 'Gastric mucosal hypertrophy'? | Hypertrophic Gastric folds with Hypomagnesemia, linking the dots.
A Caucasian man in early 80s was seen in Gastroenterology Clinic, following, referral from the Endocrinology Clinic for concerns for CT Abdomen requested for tiredness and weight loss of three kilograms. The patient also had microcytic picture with low M... | Recovering | ReactionOutcome | CC BY | 34290814 | 20,126,514 | 2021 |
What was the outcome of reaction 'Gastric polyps'? | Hypertrophic Gastric folds with Hypomagnesemia, linking the dots.
A Caucasian man in early 80s was seen in Gastroenterology Clinic, following, referral from the Endocrinology Clinic for concerns for CT Abdomen requested for tiredness and weight loss of three kilograms. The patient also had microcytic picture with low M... | Recovering | ReactionOutcome | CC BY | 34290814 | 20,126,514 | 2021 |
What was the outcome of reaction 'Weight decreased'? | Hypertrophic Gastric folds with Hypomagnesemia, linking the dots.
A Caucasian man in early 80s was seen in Gastroenterology Clinic, following, referral from the Endocrinology Clinic for concerns for CT Abdomen requested for tiredness and weight loss of three kilograms. The patient also had microcytic picture with low M... | Recovering | ReactionOutcome | CC BY | 34290814 | 20,126,514 | 2021 |
What is the weight of the patient? | Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series.
There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history o... | 67.9 kg. | Weight | CC BY-NC | 34290871 | 20,100,021 | 2021 |
What was the administration route of drug 'NIVOLUMAB'? | Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series.
There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history o... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 34290871 | 20,100,021 | 2021 |
What was the administration route of drug 'SITAGLIPTIN'? | Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series.
There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history o... | Oral | DrugAdministrationRoute | CC BY-NC | 34290871 | 20,100,021 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: A small case series.
Clinicians and researchers have reported an array of neurological abnormalities in coronavirus disease 2019 (COVID-19), and while serotonin excess has been observed we are unaware of reports of central nervous system serotonin... | LORAZEPAM | DrugsGivenReaction | CC BY-NC | 34290872 | 19,727,993 | 2021 |
What was the administration route of drug 'CYPROHEPTADINE'? | Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: A small case series.
Clinicians and researchers have reported an array of neurological abnormalities in coronavirus disease 2019 (COVID-19), and while serotonin excess has been observed we are unaware of reports of central nervous system serotonin... | Oral | DrugAdministrationRoute | CC BY-NC | 34290872 | 20,864,767 | 2021 |
What was the dosage of drug 'CYPROHEPTADINE'? | Unprovoked serotonin syndrome-like presentation of SARS-CoV-2 infection: A small case series.
Clinicians and researchers have reported an array of neurological abnormalities in coronavirus disease 2019 (COVID-19), and while serotonin excess has been observed we are unaware of reports of central nervous system serotonin... | UNK, (SCHEDULED CYPROHEPTADINE FOR 96?HOUR) | DrugDosageText | CC BY-NC | 34290872 | 20,864,767 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Henoch-Schonlein purpura'. | An Unusual Timing of Amoxicillin-Induced IgA Vasculitis in an Elderly Patient.
Immunoglobulin A vasculitis is a small vessel vasculitis which is usually common in the pediatric group. It is rare in adult population but more severe than in children. Proposed triggers include infections, malignancy and medications. For m... | AMOXICILLIN\CLAVULANATE POTASSIUM | DrugsGivenReaction | CC BY | 34290934 | 19,685,234 | 2021-06 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | An Unusual Timing of Amoxicillin-Induced IgA Vasculitis in an Elderly Patient.
Immunoglobulin A vasculitis is a small vessel vasculitis which is usually common in the pediatric group. It is rare in adult population but more severe than in children. Proposed triggers include infections, malignancy and medications. For m... | Oral | DrugAdministrationRoute | CC BY | 34290934 | 19,685,234 | 2021-06 |
What was the dosage of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | An Unusual Timing of Amoxicillin-Induced IgA Vasculitis in an Elderly Patient.
Immunoglobulin A vasculitis is a small vessel vasculitis which is usually common in the pediatric group. It is rare in adult population but more severe than in children. Proposed triggers include infections, malignancy and medications. For m... | UNKNOWN | DrugDosageText | CC BY | 34290934 | 19,685,234 | 2021-06 |
What was the outcome of reaction 'Henoch-Schonlein purpura'? | An Unusual Timing of Amoxicillin-Induced IgA Vasculitis in an Elderly Patient.
Immunoglobulin A vasculitis is a small vessel vasculitis which is usually common in the pediatric group. It is rare in adult population but more severe than in children. Proposed triggers include infections, malignancy and medications. For m... | Recovered | ReactionOutcome | CC BY | 34290934 | 19,685,234 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer.
Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEG... | BEVACIZUMAB, OXALIPLATIN, RALTITREXED | DrugsGivenReaction | CC BY | 34290985 | 20,018,674 | 2021 |
What was the dosage of drug 'BEVACIZUMAB'? | Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer.
Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEG... | UNK, Q 2W (3 COURSES) | DrugDosageText | CC BY | 34290985 | 20,018,674 | 2021 |
What was the dosage of drug 'OXALIPLATIN'? | Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer.
Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEG... | UNK (3 COURSES) | DrugDosageText | CC BY | 34290985 | 20,018,674 | 2021 |
What was the dosage of drug 'RALTITREXED'? | Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer.
Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inhibition of vascular endothelial growth factor (VEGF) receptor (VEG... | UNK (3 COURSES) | DrugDosageText | CC BY | 34290985 | 20,018,674 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | ARSENIC TRIOXIDE, CYTARABINE, DEXAMETHASONE, MANNITOL, METHOTREXATE | DrugsGivenReaction | CC BY | 34290987 | 19,949,898 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | ARSENIC TRIOXIDE, CYTARABINE, DEXAMETHASONE, MANNITOL, METHOTREXATE | DrugsGivenReaction | CC BY | 34290987 | 19,949,898 | 2021 |
What was the administration route of drug 'ARSENIC TRIOXIDE'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34290987 | 19,949,898 | 2021 |
What was the administration route of drug 'CYTARABINE'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | Intrathecal | DrugAdministrationRoute | CC BY | 34290987 | 19,949,898 | 2021 |
What was the administration route of drug 'DEXAMETHASONE'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | Intrathecal | DrugAdministrationRoute | CC BY | 34290987 | 19,949,898 | 2021 |
What was the administration route of drug 'MANNITOL'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34290987 | 19,949,898 | 2021 |
What was the administration route of drug 'METHOTREXATE'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | Intrathecal | DrugAdministrationRoute | CC BY | 34290987 | 19,949,898 | 2021 |
What was the dosage of drug 'ARSENIC TRIOXIDE'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | CONTINUOUS | DrugDosageText | CC BY | 34290987 | 19,949,898 | 2021 |
What was the dosage of drug 'MANNITOL'? | Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.
Extramedullary relapse of acute promyelocytic leukemia is a rare phenomenon and is associated with a poor prognosis, with the central nervous system being the most common site of relapse. The current treatments are... | CONTINUOUS | DrugDosageText | CC BY | 34290987 | 19,949,898 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholangitis acute'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus test positive'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal candidiasis'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancreatitis'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | HYDROXYZINE HYDROCHLORIDE, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 14,955,210 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count decreased'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count decreased'. | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
What was the administration route of drug 'ACETAMINOPHEN'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the administration route of drug 'DIPHENHYDRAMINE HYDROCHLORIDE'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the administration route of drug 'HYDROXYZINE HYDROCHLORIDE'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34291151 | 14,955,210 | 2021-08 |
What was the administration route of drug 'MYCOPHENOLATE MOFETIL'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the administration route of drug 'RITUXIMAB'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the administration route of drug 'TACROLIMUS'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the dosage of drug 'ACETAMINOPHEN'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | 500 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the dosage of drug 'DIPHENHYDRAMINE HYDROCHLORIDE'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | 30 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the dosage of drug 'HYDROXYZINE HYDROCHLORIDE'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | 25 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34291151 | 14,955,210 | 2021-08 |
What was the dosage of drug 'RITUXIMAB'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | 500 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the outcome of reaction 'Cholangitis acute'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovering | ReactionOutcome | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
What was the outcome of reaction 'Cytomegalovirus test positive'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovering | ReactionOutcome | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the outcome of reaction 'Herpes zoster'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovering | ReactionOutcome | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
What was the outcome of reaction 'Oesophageal candidiasis'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovering | ReactionOutcome | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the outcome of reaction 'Off label use'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Fatal | ReactionOutcome | CC BY-NC-ND | 34291151 | 14,955,210 | 2021-08 |
What was the outcome of reaction 'Pancreatitis'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Fatal | ReactionOutcome | CC BY-NC-ND | 34291151 | 14,955,210 | 2021-08 |
What was the outcome of reaction 'Platelet count decreased'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovered | ReactionOutcome | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
What was the outcome of reaction 'Urinary tract infection'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovering | ReactionOutcome | CC BY-NC-ND | 34291151 | 19,714,228 | 2021-08 |
What was the outcome of reaction 'White blood cell count decreased'? | Rituximab Desensitization in Liver Transplant Recipients With Preformed Donor-specific HLA Antibodies: A Japanese Nationwide Survey.
The significance of preformed donor-specific anti-HLA antibodies (DSAs) in liver transplant recipients is controversial. Moreover, there has been no established desensitization protocol f... | Recovered | ReactionOutcome | CC BY-NC-ND | 34291151 | 15,860,939 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Follicular thyroid cancer'. | Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal with... | SORAFENIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 34291429 | 20,092,163 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal with... | SORAFENIB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 34291429 | 20,092,163 | 2021-12 |
What was the administration route of drug 'SORAFENIB'? | Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal with... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34291429 | 20,092,163 | 2021-12 |
What was the administration route of drug 'ZOLEDRONIC ACID'? | Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal with... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34291429 | 20,092,163 | 2021-12 |
What was the outcome of reaction 'Follicular thyroid cancer'? | Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal with... | Fatal | ReactionOutcome | CC BY | 34291429 | 20,092,163 | 2021-12 |
What was the outcome of reaction 'Osteonecrosis of jaw'? | Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal with... | Recovering | ReactionOutcome | CC BY | 34291429 | 20,092,163 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | ADENOSINE, AMIODARONE, CALCIUM CHLORIDE, ENALAPRIL, EPINEPHRINE, FUROSEMIDE, LEVETIRACETAM, MILRINONE, PROPRANOLOL HYDROCHLORIDE, VASOPRESSIN | DrugsGivenReaction | CC BY-NC | 34293947 | 20,003,231 | 2021 |
What was the administration route of drug 'ADENOSINE'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34293947 | 20,003,231 | 2021 |
What was the administration route of drug 'CALCIUM CHLORIDE'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | Other | DrugAdministrationRoute | CC BY-NC | 34293947 | 20,058,623 | 2021 |
What was the administration route of drug 'EPINEPHRINE'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | Other | DrugAdministrationRoute | CC BY-NC | 34293947 | 20,058,623 | 2021 |
What was the administration route of drug 'MILRINONE'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | Other | DrugAdministrationRoute | CC BY-NC | 34293947 | 20,058,623 | 2021 |
What was the administration route of drug 'VASOPRESSIN'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | Other | DrugAdministrationRoute | CC BY-NC | 34293947 | 20,058,623 | 2021 |
What was the dosage of drug 'EPINEPHRINE'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | UNK, INFUSION | DrugDosageText | CC BY-NC | 34293947 | 20,003,231 | 2021 |
What was the dosage of drug 'MILRINONE'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | UNK, INFUSION | DrugDosageText | CC BY-NC | 34293947 | 20,003,231 | 2021 |
What was the dosage of drug 'VASOPRESSIN'? | Timely Use of Venous-Arterial ECMO to Treat Congenital Pediatric Junctional Ectopic Tachycardia: A Case Report.
Supraventricular tachycardia is the most common tachyarrhythmia in pediatrics. Although postoperative junctional ectopic tachycardia (JET) is a known complication of congenital heart surgery that is typically... | UNK, INFUSION | DrugDosageText | CC BY-NC | 34293947 | 20,003,231 | 2021 |
What was the dosage of drug 'ALCOHOL'? | Acute kidney injury with partial Fanconi syndrome in a patient with leptospirosis: a case report.
BACKGROUND
Leptospirosis is an underdiagnosed bacterial infection with nonspecific symptoms, hence, a diagnostic challenge. Identifying a case of leptospirosis in Switzerland is uncommon. Although kidney complications are ... | MAINLY BEER AND SPIRIT, APPROXIMATELY 185 ALCOHOL UNITS/WEEK | DrugDosageText | CC BY | 34294111 | 20,619,396 | 2021-07-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol.
BACKGROUND
Immediate hypersensitivity reaction to ursodiol is rare and there is no previously published protocol on ursodiol desensitization.
METHODS
A 59-year-old woman with primary biliary cholangitis (PBC) developed an imm... | URSODIOL | DrugsGivenReaction | CC BY | 34294117 | 19,641,969 | 2021-07-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type I hypersensitivity'. | Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol.
BACKGROUND
Immediate hypersensitivity reaction to ursodiol is rare and there is no previously published protocol on ursodiol desensitization.
METHODS
A 59-year-old woman with primary biliary cholangitis (PBC) developed an imm... | URSODIOL | DrugsGivenReaction | CC BY | 34294117 | 19,733,074 | 2021-07-22 |
What was the administration route of drug 'URSODIOL'? | Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol.
BACKGROUND
Immediate hypersensitivity reaction to ursodiol is rare and there is no previously published protocol on ursodiol desensitization.
METHODS
A 59-year-old woman with primary biliary cholangitis (PBC) developed an imm... | Oral | DrugAdministrationRoute | CC BY | 34294117 | 19,733,074 | 2021-07-22 |
What was the outcome of reaction 'Pruritus'? | Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol.
BACKGROUND
Immediate hypersensitivity reaction to ursodiol is rare and there is no previously published protocol on ursodiol desensitization.
METHODS
A 59-year-old woman with primary biliary cholangitis (PBC) developed an imm... | Recovered | ReactionOutcome | CC BY | 34294117 | 19,641,969 | 2021-07-22 |
What was the outcome of reaction 'Type I hypersensitivity'? | Immediate hypersensitivity reaction followed by successful oral desensitization to ursodiol.
BACKGROUND
Immediate hypersensitivity reaction to ursodiol is rare and there is no previously published protocol on ursodiol desensitization.
METHODS
A 59-year-old woman with primary biliary cholangitis (PBC) developed an imm... | Recovered | ReactionOutcome | CC BY | 34294117 | 19,733,074 | 2021-07-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Central Pontine Myelinolysis in a Normonatremic Patient with Depression.
A 76-year-old male presented with a recurrent depressive episode, an unsteady gait and cognitive impairment. Extensive blood tests, including hemogram, biochemical tests, folic acid, vitamin B12, and thyroid hormone, showed normal results. With th... | ARIPIPRAZOLE, LURASIDONE, QUETIAPINE FUMARATE, VENLAFAXINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34294627 | 20,662,559 | 2021-08-31 |
What was the outcome of reaction 'Drug ineffective'? | Central Pontine Myelinolysis in a Normonatremic Patient with Depression.
A 76-year-old male presented with a recurrent depressive episode, an unsteady gait and cognitive impairment. Extensive blood tests, including hemogram, biochemical tests, folic acid, vitamin B12, and thyroid hormone, showed normal results. With th... | Recovered | ReactionOutcome | CC BY-NC | 34294627 | 19,741,676 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute stress disorder'. | Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report.
Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It seems to have a favorable metabolic profile and low risk of causing adverse interactions. Here we present a case ... | LAMOTRIGINE, LURASIDONE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34294628 | 19,663,796 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aggression'. | Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report.
Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It seems to have a favorable metabolic profile and low risk of causing adverse interactions. Here we present a case ... | LAMOTRIGINE, LURASIDONE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34294628 | 19,663,796 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report.
Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It seems to have a favorable metabolic profile and low risk of causing adverse interactions. Here we present a case ... | LAMOTRIGINE, LURASIDONE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34294628 | 19,663,796 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hallucination, auditory'. | Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report.
Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It seems to have a favorable metabolic profile and low risk of causing adverse interactions. Here we present a case ... | LAMOTRIGINE, LURASIDONE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34294628 | 19,663,796 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ideas of reference'. | Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report.
Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It seems to have a favorable metabolic profile and low risk of causing adverse interactions. Here we present a case ... | LAMOTRIGINE, LURASIDONE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34294628 | 19,663,796 | 2021-08-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mood altered'. | Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report.
Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia and bipolar depression. It seems to have a favorable metabolic profile and low risk of causing adverse interactions. Here we present a case ... | LAMOTRIGINE, LURASIDONE HYDROCHLORIDE, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 34294628 | 19,663,796 | 2021-08-31 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.